Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Sun Pharma Advanced Research patents new tyrosine kinase inhibitors

Dec. 5, 2016

The Center Translational Drug Development patents novel Rho kinase inhibitors

Dec. 5, 2016

Kainos Medicine presents Brd4 inhibitors

Dec. 2, 2016

Medshine Discovery develops PDE2A inhibitors and TNF-alpha production inhibitors

Dec. 2, 2016

GlaxoSmithKline describes RIP-1 kinase 1 inhibitors

Dec. 2, 2016

Wistar Institute discloses EBNA-1 inhibitors

Dec. 2, 2016

Kalyra Pharmaceuticals patents EGFR inhibitors

Dec. 2, 2016

Boehringer Ingelheim prepares and tests IGF-1R inhibitors

Dec. 1, 2016

Roche patent describes TLR7 agonists for HBV infections

Dec. 1, 2016

Selvita reports PFKFB inhibitors in patent

Dec. 1, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...